Rubicon Organics Inc. Share Price Canadian Securities Exchange
Equities
ROMJ
CA78112W1005
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.1 CAD | +7.89% | +15.82% | +13.26% |
28/03 | Rubicon Organics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
28/03 | Transcript : Rubicon Organics Inc., Q4 2023 Earnings Call, Mar 28, 2024 |
Sales 2024 * | 44.69M 32.67M 2.73B | Sales 2025 * | 48.36M 35.35M 2.95B | Capitalization | 21.35M 15.61M 1.3B |
---|---|---|---|---|---|
Net income 2024 * | -1M -731K -60.98M | Net income 2025 * | - 0 0 | EV / Sales 2024 * | 0.48 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 0.44 x |
P/E ratio 2024 * |
-19
x | P/E ratio 2025 * |
-38
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 45.84% |
Latest transcript on Rubicon Organics Inc.
1 day | +7.89% |
Managers | Title | Age | Since |
---|---|---|---|
Margaret Brodie
CEO | Chief Executive Officer | 46 | 10/16/10 |
Janis Risbin
DFI | Director of Finance/CFO | 44 | - |
Peter Dierx
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
David Donnan
BRD | Director/Board Member | 68 | 24/19/24 |
Director/Board Member | 60 | 20/23/20 | |
Margaret Brodie
CEO | Chief Executive Officer | 46 | 10/16/10 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.96% | 272M | |
+33.74% | 261M | |
+49.42% | 194M | |
+44.98% | 131M | |
-28.57% | 121M | |
+115.91% | 119M | |
0.00% | 86.82M | |
+150.00% | 75.33M | |
+1.20% | 55.24M |
- Stock Market
- Equities
- ROMJ Stock
- ROMJ Stock